
NewGenIvf Group Limited Class A ordinary shares
NIVFNewGenIVF Group Limited is a fertility services provider specializing in assisted reproductive technologies and reproductive health services. The company offers comprehensive solutions including IVF treatments, egg donation, fertility preservation, and other related healthcare services. Operating primarily in Asia, NewGenIVF focuses on delivering advanced reproductive procedures with a commitment to patient care and medical innovation.
Company News
NewGen Group Limited (Nasdaq: NIVF) announced a Big Four valuation of US$19 million for its planned UAE-based cell sorting and cytometry leasing business, building on a prior US$17.9 million IP valuation. The company appointed industry veteran Nadeem Malik as Senior Strategic Advisor to lead the UAE/GCC expansion, targeting the high-growth IVF ma...
NewGenIvf Group (NASDAQ: NIVF) shares surged 67.8% in premarket trading on Wednesday following the company's announcement to repurchase all outstanding convertible notes and warrants from a significant investor. The move aims to strengthen the capital structure, eliminate potential dilution, and provide greater clarity for shareholders. The stock...
NewGenIvf Group acquired advanced cytometry intellectual property, receiving a valuation of $17.9 million, which boosts the company's net asset value and marks a strategic transition from traditional IVF services to a technology-driven service provider.
NewGenDigital, a subsidiary of NewGenIvf Group, has secured a strategic 110,400 sq. ft. plot in Ras Al Khaimah, UAE, and is exploring real world asset tokenization using blockchain technology, with potential sales revenue exceeding $400 million.
NewGenIVF, a fertility services provider in Asia, has terminated its proposed reverse merger transaction with European Wellness Investment Holdings Limited due to the latter's failure to deliver required financial statements by the deadline.

